Selective sPlenic flExure Mobilization for Low colorEctal Anastomosis After D3 lYmph Node Dissection (Speedy Trial) (SpeeDy)

February 26, 2020 updated by: Russian Society of Colorectal Surgeons

Randomized Non-inferiority Trial of Selective Splenic Flexure Mobilization for the Formation of Low Colorectal Anastomosis After Total Mesorectal Excision and D3 Paraaortic Lymph Node Dissection in Low Rectal Cancer.

In the Low Anterior Resection of rectum for cancer, the section level of IMA and the need of SFM is still debated.

The aim of this study is to explore the different impacts of high and low ligation with peeling off vascular sheath of inferior mesenteric artery (IMA) in low anterior resection of the rectum for cancer. This study purpose to demonstrate that low IMA ligation, sparing of left colic artery (LCA) and selective SFM results in higher anastomotic leakage rate than high IMA ligation with routine SFM (with the difference of more than 5%).

Study Overview

Detailed Description

Although TME is the standard curative operation for rectal cancer patients, who undergo low anterior resection (LAR) or abdominoperineal resection (APR) with a permanent colostomy, the strategy to restore the transit between colon and rectum (in case of LAR) is still debated in literature.

Several studies comparing high-tie with low-tie ligation reported a stage-specific survival benefit for high-tie, but on the other hand recent studies demonstrated that low-tie, without splenic flexure mobilization (SFM), decreases the complexity of the laparoscopic procedure and could reduces the operating time with comparable oncological outcomes.

The method of restorative surgery, after Total Mesorectal Excision (TME), largely depends on the length of the resected part of the colon, that is related to patient's anatomical features and the height of vascular ligation performed during the operation.

In attempt to perform a radical paraaortic lymph node dissection the inferior mesenteric artery (IMA) is usually ligated at its origin and the Arcade of Riolan provides bloody supply to any distal anastomosis. Unfortunately the Arcade of Riolan is an inconstant finding and sometimes (26% of cases) is mandatory to mobilize the splenic flexure to ensure a safe and tension-free anastomosis. SFM is a time-consuming component of LAR, has the additional risk of iatrogenic splenic injury and is very difficult during a laparoscopic resection.

In 2005 was demonstrated that routine SFM is not always necessary during anterior resection for rectal cancer.

A recent retrospective analysis by Mouw showed that SFM was associated with wider margins and a decreased rate of inadequate nodal staging in patients undergoing LAR.

This trial aims to demonstrate that low IMA ligation, sparing of LCA and selective SFM results in higher anastomotic leakage rate than high IMA ligation with routine SFM (with the difference of more than 5%). Furthermore this study purpose to evaluate the need to perform splenic flexure mobilization (SFM) in low ligation group and the, operation time, apical lymph nodes positive rate and short terms postoperative complication in both groups

Study Type

Interventional

Enrollment (Anticipated)

142

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Moscow, Russian Federation, 119435
        • Recruiting
        • Clinic of Colorectal and Minimally Invasive Surgery
        • Principal Investigator:
          • Petr Tsarkov, Prof
        • Sub-Investigator:
          • Inna Tulina, MD
        • Sub-Investigator:
          • Victor Zhurkovsky, MD
        • Sub-Investigator:
          • Lyudmila Sidorova, MD
        • Sub-Investigator:
          • Arcangelo Picciariello, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Histologically proven primary rectal adenocarcinoma located within 15 cm from anal verge not involving internal and/or external sphincter muscle
  2. Stage I-III
  3. Elective surgical treatment with TME and primary colorectal anastomosis
  4. Receive or not receive neoadjuvant radio-chemotherapy
  5. Overall health status according to American Society of Anesthesiologists (ASA) classification: I-III
  6. Signed informed consent with agreement to attend all study visits
  7. The patient is not pregnant

Exclusion Criteria:

  1. Unresectable tumour, inability to perform a TME with colorectal anastomosis, inability to complete R0 resection or presence of T4b tumour necessitating a multi-organ resection
  2. The patient wants to withdraw from the clinical trial
  3. Loss to follow-up
  4. Inability to complete all the trial procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: IMA high ligation with routine SFM
Inferior mesenteric artery is ligated close to its origin. Splenic flexure is always mobilized.
Nerve-sparing paraaortic lymph node dissection is performed. The inferior mesenteric artery is divided at 1-2 cm from its origin from the aorta. Nerve-sparing total mesorectal excision is performed. Splenic flexure is mobilized. Side-to-end sigmoido-rectal anastomosis is created.
Other Names:
  • High tie with routine SFM
Experimental: IMA skeletonization and low ligation with selective SFM
Inferior mesenteric artery is ligated below the origin of left colic artery. Splenic flexure is mobilized only if needed.
Nerve-sparing paraaortic lymph node dissection is performed. Then inferior mesenteric artery is skeletonized down to the origin of left colic artery and divided below it. Nerve-sparing total mesorectal excision is performed. Splenic flexure is mobilized only if sigmoid colon is unsuitable for anastomosis or doesn't reach the rectal stump. Then descending-rectal side-to-end anastomosis is created.
Other Names:
  • Low tie with selective SFM

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anastomotic Leakage Rate
Time Frame: 4-6 weeks
The rate of symptomatic and asymptomatic colorectal anastomotic leakage
4-6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Early postoperative complications rate
Time Frame: 30 days
The rate of complications in first 30 days after surgery
30 days
Operating time
Time Frame: 1 day
The duration of surgical procedure
1 day
Intraoperative complications rate
Time Frame: 1 day
The rate of complications during surgery
1 day
Splenic flexure mobilization rate
Time Frame: 1 day
The rate of splenic flexure mobilization in Low tie group
1 day
Conversion rate
Time Frame: 1 day
The rate of conversion from laparoscopic or robotic approach to open approach
1 day
IMA architectonics
Time Frame: 1 day
The incidence of left colic artery, first, second and third sigmoid arteries
1 day
The length of IMA trunk
Time Frame: 1 day
the length of inferior mesenteric artery trunk based on preoperative CT-scans and intraoperative findings
1 day
Specimen morphometry
Time Frame: 30 days
The gross dimensions of resected specimen: length, the distal and proximal resection margins distance, vascular pedicle length
30 days
Positive Apical Lymph Nodes Rate
Time Frame: 30 days
The rate of metastatic lymph nodes found in the area of paraaortic lymph node dissection
30 days
Complications of defunctioning stoma
Time Frame: 3 month
Any complications of defunctioning stoma
3 month
The postoperative hospital stay
Time Frame: 1 month
the number of days from the first day after operation to discharge
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 2, 2016

Primary Completion (Anticipated)

May 2, 2020

Study Completion (Anticipated)

November 2, 2021

Study Registration Dates

First Submitted

March 28, 2019

First Submitted That Met QC Criteria

March 28, 2019

First Posted (Actual)

March 29, 2019

Study Record Updates

Last Update Posted (Actual)

February 27, 2020

Last Update Submitted That Met QC Criteria

February 26, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rectal Cancer

3
Subscribe